カテゴリー： QYResearch, 世界

膿痂疹治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Impetigo Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18560）・商品コード：DATA909X18560
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：93
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、膿痂疹治療の世界市場について調査・分析し、膿痂疹治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（セファロスポリン、フシダン、リンコサミド抗生物質、ペニシリン、ペニシリン様抗生物質、プロイロムチリン、プソドモン酸A、キノロン、スルホンアミドおよび葉酸阻害剤、テトラサイクリン）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の膿痂疹治療市場動向
・主要企業別マーケットシェア
・膿痂疹治療の種類別市場規模2014-2019
（セファロスポリン、フシダン、リンコサミド抗生物質、ペニシリン、ペニシリン様抗生物質、プロイロムチリン、プソドモン酸A、キノロン、スルホンアミドおよび葉酸阻害剤、テトラサイクリン）
・膿痂疹治療の用途別市場規模2014-2019
（病院、診療所、その他）
・膿痂疹治療の北米市場：主要企業・種類別/用途別市場規模
・膿痂疹治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・膿痂疹治療の中国市場：主要企業・種類別/用途別市場規模
・膿痂疹治療の日本国内市場：主要企業・種類別/用途別市場規模
・膿痂疹治療の東南アジア市場：主要企業・種類別/用途別市場規模
・膿痂疹治療のインド市場：主要企業・種類別/用途別市場規模
・膿痂疹治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（GlaxoSmithKline plc、Karalex Pharma, LLC、Leo Pharma A/S、Lupin Limited、NovaBay Pharmaceuticals, Inc.、Pfizer, Inc.、Ranbaxy Laboratories Limited、Roche Holding AG、SANDOZ GmbH、Taro Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd）
・膿痂疹治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.In 2018, the global Impetigo Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Impetigo Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Impetigo Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
GlaxoSmithKline plc
Karalex Pharma, LLC
Leo Pharma A/S
Lupin Limited
NovaBay Pharmaceuticals, Inc.
Pfizer, Inc.
Ranbaxy Laboratories Limited
Roche Holding AG
SANDOZ GmbH
Taro Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd

Market segment by Type, the product can be split into
Cephalosporins
Fusidane
Lincosamide Antibiotic
Penicillin
Penicillin-Like Antibiotics
Pleuromutilin
Pseudomonic Acid A
Quinolone
Sulfonamides And Folic Acid Inhibitors
Tetracyclines

Market segment by Application, split into
Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Impetigo Treatment status, future forecast, growth opportunity, key market and key players.
To present the Impetigo Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Impetigo Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Impetigo Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Cephalosporins
1.4.3 Fusidane
1.4.4 Lincosamide Antibiotic
1.4.5 Penicillin
1.4.6 Penicillin-Like Antibiotics
1.4.7 Pleuromutilin
1.4.8 Pseudomonic Acid A
1.4.9 Quinolone
1.4.10 Sulfonamides And Folic Acid Inhibitors
1.4.11 Tetracyclines
1.5 Market by Application
1.5.1 Global Impetigo Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Impetigo Treatment Market Size
2.2 Impetigo Treatment Growth Trends by Regions
2.2.1 Impetigo Treatment Market Size by Regions (2019-2025)
2.2.2 Impetigo Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Impetigo Treatment Market Size by by Players
3.1.1 Global Impetigo Treatment Revenue by by Players (2014-2019)
3.1.2 Global Impetigo Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Impetigo Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Impetigo Treatment Key Players Head office and Area Served
3.3 Key Players Impetigo Treatment Product/Solution/Service
3.4 Date of Enter into Impetigo Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Impetigo Treatment Market Size by Type (2014-2019)
4.2 Global Impetigo Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Impetigo Treatment Market Size (2014-2019)
5.2 Impetigo Treatment Key Players in North America
5.3 North America Impetigo Treatment Market Size by Type
5.4 North America Impetigo Treatment Market Size by Application

6 Europe
6.1 Europe Impetigo Treatment Market Size (2014-2019)
6.2 Impetigo Treatment Key Players in Europe
6.3 Europe Impetigo Treatment Market Size by Type
6.4 Europe Impetigo Treatment Market Size by Application

7 China
7.1 China Impetigo Treatment Market Size (2014-2019)
7.2 Impetigo Treatment Key Players in China
7.3 China Impetigo Treatment Market Size by Type
7.4 China Impetigo Treatment Market Size by Application

8 Japan
8.1 Japan Impetigo Treatment Market Size (2014-2019)
8.2 Impetigo Treatment Key Players in Japan
8.3 Japan Impetigo Treatment Market Size by Type
8.4 Japan Impetigo Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Impetigo Treatment Market Size (2014-2019)
9.2 Impetigo Treatment Key Players in Southeast Asia
9.3 Southeast Asia Impetigo Treatment Market Size by Type
9.4 Southeast Asia Impetigo Treatment Market Size by Application

10 India
10.1 India Impetigo Treatment Market Size (2014-2019)
10.2 Impetigo Treatment Key Players in India
10.3 India Impetigo Treatment Market Size by Type
10.4 India Impetigo Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Impetigo Treatment Market Size (2014-2019)
11.2 Impetigo Treatment Key Players in Central & South America
11.3 Central & South America Impetigo Treatment Market Size by Type
11.4 Central & South America Impetigo Treatment Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline plc
12.1.1 GlaxoSmithKline plc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Impetigo Treatment Introduction
12.1.4 GlaxoSmithKline plc Revenue in Impetigo Treatment Business (2014-2019))
12.1.5 GlaxoSmithKline plc Recent Development
12.2 Karalex Pharma, LLC
12.2.1 Karalex Pharma, LLC Company Details
12.2.2 Company Description and Business Overview
12.2.3 Impetigo Treatment Introduction
12.2.4 Karalex Pharma, LLC Revenue in Impetigo Treatment Business (2014-2019)
12.2.5 Karalex Pharma, LLC Recent Development
12.3 Leo Pharma A/S
12.3.1 Leo Pharma A/S Company Details
12.3.2 Company Description and Business Overview
12.3.3 Impetigo Treatment Introduction
12.3.4 Leo Pharma A/S Revenue in Impetigo Treatment Business (2014-2019)
12.3.5 Leo Pharma A/S Recent Development
12.4 Lupin Limited
12.4.1 Lupin Limited Company Details
12.4.2 Company Description and Business Overview
12.4.3 Impetigo Treatment Introduction
12.4.4 Lupin Limited Revenue in Impetigo Treatment Business (2014-2019)
12.4.5 Lupin Limited Recent Development
12.5 NovaBay Pharmaceuticals, Inc.
12.5.1 NovaBay Pharmaceuticals, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Impetigo Treatment Introduction
12.5.4 NovaBay Pharmaceuticals, Inc. Revenue in Impetigo Treatment Business (2014-2019)
12.5.5 NovaBay Pharmaceuticals, Inc. Recent Development
12.6 Pfizer, Inc.
12.6.1 Pfizer, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Impetigo Treatment Introduction
12.6.4 Pfizer, Inc. Revenue in Impetigo Treatment Business (2014-2019)
12.6.5 Pfizer, Inc. Recent Development
12.7 Ranbaxy Laboratories Limited
12.7.1 Ranbaxy Laboratories Limited Company Details
12.7.2 Company Description and Business Overview
12.7.3 Impetigo Treatment Introduction
12.7.4 Ranbaxy Laboratories Limited Revenue in Impetigo Treatment Business (2014-2019)
12.7.5 Ranbaxy Laboratories Limited Recent Development
12.8 Roche Holding AG
12.8.1 Roche Holding AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Impetigo Treatment Introduction
12.8.4 Roche Holding AG Revenue in Impetigo Treatment Business (2014-2019)
12.8.5 Roche Holding AG Recent Development
12.9 SANDOZ GmbH
12.9.1 SANDOZ GmbH Company Details
12.9.2 Company Description and Business Overview
12.9.3 Impetigo Treatment Introduction
12.9.4 SANDOZ GmbH Revenue in Impetigo Treatment Business (2014-2019)
12.9.5 SANDOZ GmbH Recent Development
12.10 Taro Pharmaceutical Industries Ltd
12.10.1 Taro Pharmaceutical Industries Ltd Company Details
12.10.2 Company Description and Business Overview
12.10.3 Impetigo Treatment Introduction
12.10.4 Taro Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2014-2019)
12.10.5 Taro Pharmaceutical Industries Ltd Recent Development
12.11 Teva Pharmaceutical Industries Ltd

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Impetigo Treatment Key Market Segments
Table Key Players Impetigo Treatment Covered
Table Global Impetigo Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Cephalosporins Figures
Table Key Players of Cephalosporins
Figuer Fusidane Figures
Table Key Players of Fusidane
Figuer Lincosamide Antibiotic Figures
Table Key Players of Lincosamide Antibiotic
Figuer Penicillin Figures
Table Key Players of Penicillin
Figuer Penicillin-Like Antibiotics Figures
Table Key Players of Penicillin-Like Antibiotics
Figuer Pleuromutilin Figures
Table Key Players of Pleuromutilin
Figuer Pseudomonic Acid A Figures
Table Key Players of Pseudomonic Acid A
Figuer Quinolone Figures
Table Key Players of Quinolone
Figuer Sulfonamides And Folic Acid Inhibitors Figures
Table Key Players of Sulfonamides And Folic Acid Inhibitors
Figuer Tetracyclines Figures
Table Key Players of Tetracyclines
Table Global Impetigo Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Impetigo Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Impetigo Treatment Report Years Considered
Figure Global Impetigo Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Impetigo Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Impetigo Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Impetigo Treatment Market Share by Regions 2014-2019
Figure Global Impetigo Treatment Market Share by Regions 2014-2019
Figure Global Impetigo Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Impetigo Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Impetigo Treatment Market Share by by Players (2014-2019)
Figure Global Impetigo Treatment Market Share by by Players in 2018
Table Global Impetigo Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Impetigo Treatment Product/Solution/Service
Table Date of Enter into Impetigo Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Impetigo Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Impetigo Treatment Market Size Share by Type (2014-2019)
Figure Global Impetigo Treatment Market Size Market Share by Type (2014-2019)
Table Global Impetigo Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Impetigo Treatment Market Size Share by Application (2014-2019)
Figure Global Impetigo Treatment Market Size Market Share by Application (2014-2019)
Figure Global Impetigo Treatment Revenue Market Share by Application in 2018
Figure North America Impetigo Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Impetigo Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Impetigo Treatment Market Share (2018-2019)
Table North America Impetigo Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Impetigo Treatment Market Share by Type 2014-2019
Table North America Impetigo Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Impetigo Treatment Market Share by Application 2014-2019
Figure Europe Impetigo Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Impetigo Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Impetigo Treatment Market Share (2018-2019)
Table Europe Impetigo Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Impetigo Treatment Market Share by Type 2014-2019
Table Europe Impetigo Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Impetigo Treatment Market Share by Application 2014-2019
Figure China Impetigo Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Impetigo Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Impetigo Treatment Market Share (2018-2019)
Table China Impetigo Treatment Market Size by Type 2014-2019 (Million US$)
Table China Impetigo Treatment Market Share by Type 2014-2019
Table China Impetigo Treatment Market Size by Application 2014-2019 (Million US$)
Table China Impetigo Treatment Market Share by Application 2014-2019
Figure Japan Impetigo Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Impetigo Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Impetigo Treatment Market Share (2018-2019)
Table Japan Impetigo Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Impetigo Treatment Market Share by Type 2014-2019
Table Japan Impetigo Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Impetigo Treatment Market Share by Application 2014-2019
Figure Southeast Asia Impetigo Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Impetigo Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Impetigo Treatment Market Share (2018-2019)
Table Southeast Asia Impetigo Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Impetigo Treatment Market Share by Type 2014-2019
Table Southeast Asia Impetigo Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Impetigo Treatment Market Share by Application 2014-2019
Figure India Impetigo Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Impetigo Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Impetigo Treatment Market Share (2018-2019)
Table India Impetigo Treatment Market Size by Type 2014-2019 (Million US$)
Table India Impetigo Treatment Market Share by Type 2014-2019
Table India Impetigo Treatment Market Size by Application 2014-2019 (Million US$)
Table India Impetigo Treatment Market Share by Application 2014-2019
Figure Central & South America Impetigo Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Impetigo Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Impetigo Treatment Market Share (2018-2019)
Table Central & South America Impetigo Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Impetigo Treatment Market Share by Type 2014-2019
Table Central & South America Impetigo Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Impetigo Treatment Market Share by Application 2014-2019
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Karalex Pharma, LLC Company Details
Table Karalex Pharma, LLC Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure Karalex Pharma, LLC Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table Karalex Pharma, LLC Recent Development
Table Leo Pharma A/S Company Details
Table Leo Pharma A/S Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure Leo Pharma A/S Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table Leo Pharma A/S Recent Development
Table Lupin Limited Company Details
Table Lupin Limited Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure Lupin Limited Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table Lupin Limited Recent Development
Table NovaBay Pharmaceuticals, Inc. Company Details
Table NovaBay Pharmaceuticals, Inc. Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure NovaBay Pharmaceuticals, Inc. Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table NovaBay Pharmaceuticals, Inc. Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table Ranbaxy Laboratories Limited Company Details
Table Ranbaxy Laboratories Limited Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure Ranbaxy Laboratories Limited Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table Ranbaxy Laboratories Limited Recent Development
Table Roche Holding AG Company Details
Table Roche Holding AG Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure Roche Holding AG Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table Roche Holding AG Recent Development
Table SANDOZ GmbH Company Details
Table SANDOZ GmbH Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure SANDOZ GmbH Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table SANDOZ GmbH Recent Development
Table Taro Pharmaceutical Industries Ltd Company Details
Table Taro Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business 2014-2019 (Million US$)
Figure Taro Pharmaceutical Industries Ltd Revenue Growth Rate in Impetigo Treatment Business (2014-2019)
Table Taro Pharmaceutical Industries Ltd Recent Development
Table Teva Pharmaceutical Industries Ltd Company Details
Table Global Impetigo Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Impetigo Treatment Market Size Share by Regions (2019-2025)
Figure Global Impetigo Treatment Market Size Share by Regions in 2025
Figure North America Impetigo Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Impetigo Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Impetigo Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Impetigo Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Impetigo Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Impetigo Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Impetigo Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Impetigo Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Impetigo Treatment Market Size by Product (2019-2025)
Figure Global Impetigo Treatment Market Size by Product in 2025
Table Global Impetigo Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Impetigo Treatment Market Size by Application (2019-2025)
Figure Global Impetigo Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

GlaxoSmithKline plc、Karalex Pharma, LLC、Leo Pharma A/S、Lupin Limited、NovaBay Pharmaceuticals, Inc.、Pfizer, Inc.、Ranbaxy Laboratories Limited、Roche Holding AG、SANDOZ GmbH、Taro Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd

★調査レポート[膿痂疹治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18560)販売に関する免責事項を必ずご確認ください。
★調査レポート[膿痂疹治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 悪性腹水治療の世界市場：規模・現状・予測2019-2025
    DATA909X18661 / QYResearch / 2019年11月25日 / ※当調査レポートでは、悪性腹水治療の世界市場について調査・分析し、悪性腹水治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（穿刺、化学療法、外科的治療）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の悪性腹水治療市場動向 ・主要企業別マーケットシェア ・悪性腹水治療の種類別市場規模2014-2019 （穿刺、化学療法、外科的治療） ・悪性腹水治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・悪性腹水治療の北米市場：主要企業・種類別/用途別市場規模 ・悪性腹水治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Ascites are characterized by excess fluid formation in the abdominal cavity, especially in the peritoneal cavity. It causes the body to lose fluids. When ascites develop due to cancer, it is called malignant peritoneal effusion or malignant ascites.In 2018, the global Malignant Ascites Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Malignant Ascites Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Ascites Treatment...
  • 胆道閉鎖症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18226 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胆道閉鎖症治療の世界市場について調査・分析し、胆道閉鎖症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆道閉鎖症治療市場動向 ・主要企業別マーケットシェア ・胆道閉鎖症治療の種類別市場規模2014-2019 （薬物治療、外科治療） ・胆道閉鎖症治療の用途別市場規模2014-2019 （病院、診療所、その他） ・胆道閉鎖症治療の北米市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.In 2018, the global Biliary Atresia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Biliary Atresia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biliary...
  • 慢性片頭痛治療の世界市場：規模・現状・予測2019-2025
    DATA909X18277 / QYResearch / 2019年11月25日 / ※当調査レポートでは、慢性片頭痛治療の世界市場について調査・分析し、慢性片頭痛治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、代替治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の慢性片頭痛治療市場動向 ・主要企業別マーケットシェア ・慢性片頭痛治療の種類別市場規模2014-2019 （薬物治療、代替治療） ・慢性片頭痛治療の用途別市場規模2014-2019 （病院、診療所、その他） ・慢性片頭痛治療の北米市場：主要企業・種類別/用途別市場規模 ・慢性片頭痛治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Migraine is a painful, episodic disease that sometimes develops into a chronic condition. It is one of the most common neurological diseases in clinical practice. Chronic migraines (CM) are a natural progression of chronic migraines, with a frequency of 15 days per month and similar characteristics to migraine attacks.In 2018, the global Chronic Migraine Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Chronic Migraine Treatment status, future forecast, growth opportunity, key market and key...
  • シロアリ駆除の世界市場：規模・現状・予測2019-2025
    DATA909X19024 / QYResearch / 2019年11月25日 / ※当調査レポートでは、シロアリ駆除の世界市場について調査・分析し、シロアリ駆除の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非化学的駆除、化学的駆除）、用途別（商業、住宅、産業、農業）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のシロアリ駆除市場動向 ・主要企業別マーケットシェア ・シロアリ駆除の種類別市場規模2014-2019 （非化学的駆除、化学的駆除） ・シロアリ駆除の用途別市場規模2014-2019 （商業、住宅、産業、農業） ・シロアリ駆除の北米市場：主要企業・種類別/用途別市場規模 ・シロアリ駆除のヨーロッパ市場：主要企業・種類別/用途別市場規模...A defined liquid termite treatment, using an approved termiticide, requires you to trench and treat the foundation, drill and treat all slabs touching the house, drill and treat the front stoop on basement home and treat around the piers in a crawl space.In 2018, the global Termite Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Termite Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the...
  • 胞巣状横紋筋肉腫治療の世界市場：規模・現状・予測2019-2025
    DATA909X18151 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胞巣状横紋筋肉腫治療の世界市場について調査・分析し、胞巣状横紋筋肉腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（外科手術、化学療法、放射線療法）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胞巣状横紋筋肉腫治療市場動向 ・主要企業別マーケットシェア ・胞巣状横紋筋肉腫治療の種類別市場規模2014-2019 （外科手術、化学療法、放射線療法） ・胞巣状横紋筋肉腫治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・胞巣状横紋筋肉腫治療の北米市場：主要企業・種類別/用途別市場規模 ・胞巣状横紋筋肉腫治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Alveolar rhabdomyosarcoma (ARMS) is a type of soft tissue sarcoma that originates from the connective tissues of the body such as bone, muscle, cartilage, and ligaments.In 2018, the global Alveolar Rhabdomyosarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Alveolar Rhabdomyosarcoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alveolar Rhabdomyosarcoma Treatment development in North America, Europe and Asia-Pacific. The key players covered in...
  • HIV関連リポジストロフィー症候群治療の世界市場：規模・現状・予測2019-2025
    DATA909X18542 / QYResearch / 2019年11月25日 / ※当調査レポートでは、HIV関連リポジストロフィー症候群治療の世界市場について調査・分析し、HIV関連リポジストロフィー症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（特定薬物治療、美容矯正治療）、用途別（病院、専門医院、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のHIV関連リポジストロフィー症候群治療市場動向 ・主要企業別マーケットシェア ・HIV関連リポジストロフィー症候群治療の種類別市場規模2014-2019 （特定薬物治療、美容矯正治療） ・HIV関連リポジストロフィー症候群治療の用途別市場規模2014-2019 （病院、専門医院、その他） ・HIV関連リポジストロフィー症候群治療の北米市場：主要企業・種類別/用途別市場規模 ・HIV関連リポジストロフィー症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Lipodystrophy syndrome groups together three clinical conditions characterized by abnormal body fat distribution: lipoatrophy, lipoaccumulation and a mixed syndrome. In 2018, the global HIV Associated Lipodystrophy Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global HIV Associated Lipodystrophy Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HIV Associated Lipodystrophy Syndrome Treatment development in North America, Europe and Asia-Pacific. The key players covered in this...

    • ◆H&Iグローバルリサーチのお客様（例）◆